Synthaverse S.A.
BML | WAR
Overview
Corporate Details
- ISIN(s):
- PLBMDLB00018 (+3 more)
- LEI:
- 259400OWZM67D079S374
- Country:
- Poland
- Address:
- LUBLIN UNIWERSYTECKA 10, 20-029 LUBLIN
- Website:
- https://synthaverse.com/en/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
We are a global pharmaceutical company whose goal is to provide the best, innovative and unique solutions for medicine. Our work is based on scientific and health knowledge. Along with our expert approach, it allows us to create reliable and unique products. We are constantly developing our competences. One of our leading achievements is on advancing field of immunotherapy. We manufacture one of the few drugs used internationally in the oncological immunotherapy of bladder cancer. We have also created an anti-tuberculosis vaccine, which is used to vaccinate all newborns in the country. It is widely used all over the world. Scientific knowledge and many years of experience in the cultivation of bacterial strains have allowed us to create one of the best probiotics on the market - Lakcid®, which is one of the few probiotic drugs available in the world.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-14 17:47 |
Board/Management Change
Rozszerzenie składu zarządu Spółki Synthaverse S.A. - Content (PL)
|
Polish | 4.9 KB | |
| 2025-07-09 17:51 |
Takeover Announcement Report
zal01_FormularzF.pdf
|
Polish | 89.4 KB | |
| 2025-07-09 17:51 |
Major Shareholding Notification
Znaczne pakiety akcji - zmiana w ogólnej liczbie głosów - Content (PL)
|
Polish | 669 bytes | |
| 2025-07-08 17:47 |
Takeover Announcement Report
zal01_FormularzA_ponizej_5_proc.pdf
|
Polish | 77.8 KB | |
| 2025-07-08 17:47 |
Takeover Announcement Report
zal02_FormularzA_powyzej_5_proc.pdf
|
Polish | 77.8 KB | |
| 2025-07-08 17:47 |
Takeover Announcement Report
Znaczne pakiety akcji - zmiana w ogólnej liczbie głosów - Content (PL)
|
Polish | 529 bytes | |
| 2025-07-08 16:12 |
Takeover Announcement Report
zal01_Zawiadomienie_o_stanie_posiadania.pdf
|
Polish | 374.5 KB | |
| 2025-07-08 16:12 |
Takeover Announcement Report
Znaczne pakiety akcji - zmiana w ogólnej liczbie głosów. - Content (PL)
|
Polish | 481 bytes | |
| 2025-07-08 09:37 |
Takeover Announcement Report
zal01_FormularzA.pdf
|
Polish | 78.7 KB | |
| 2025-07-08 09:37 |
Takeover Announcement Report
Znaczne pakiety akcji - zmiana w ogólnej liczbie głosów. - Content (PL)
|
Polish | 537 bytes | |
| 2025-07-05 15:54 |
Regulatory News Service
zal03_pdf_852875.pdf
|
Polish | 4.5 KB | |
| 2025-07-05 15:54 |
Regulatory News Service
zal02_pdf_852849.pdf
|
Polish | 4.3 KB | |
| 2025-07-05 15:54 |
Regulatory News Service
zal01_pdf_852819.pdf
|
Polish | 4.5 KB | |
| 2025-07-05 15:54 |
Regulatory News Service
zal04_pdf_852681.pdf
|
Polish | 4.4 KB | |
| 2025-07-05 15:54 |
Regulatory News Service
zal05_pdf_852546.pdf
|
Polish | 4.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |